Kristina Ward, Pharm.D., BCPS

Clinical Associate Professor
Department of Pharmacy Practice
kward@uri.edu

Education

Bachelor of Science, Pharmacy, University of Rhode Island, 1994

Doctor of Pharmacy, University of Pittsburgh, 1996

Residency/Fellowship

ASHP-accredited Pharmacy Practice Residency, University Medical Center, Jacksonville FL, 1996-1997

ASHP-accredited Specialty Residency in Drug Information Practice, University Medical Center, Jacksonville FL, 1997-1998

Clinical Practice Site

URI College of Pharmacy Drug Information Service

Research / Teaching Interests

Dr. Ward is currently Clinical Associate Professor and Director of Drug Information Services at the University of Rhode Island College of Pharmacy.  The mission of Drug Information Services is twofold: to provide healthcare practitioners with timely, evidence-based drug information to promote the safe, rational use of medications and to serve as a training site for Doctor of Pharmacy students and post-doctoral residents.

Dr. Ward coordinates Drug Information and the Analysis of Literature, a required class during the spring of the first professional year.  Dr. Ward also lectures in the third professional year about Women’s Health including contraception, dysmenorrhea, infertility, and pregnancy and lactation during the integrated Gastrointestinal and Endocrine diseases portion of the curriculum.  Dr. Ward offers an Advanced Pharmacy Practice Experience (APPE) rotation in Drug Information at Drug Information Services.

Dr. Ward’s research interests include health literacy among the elderly, the portrayal of illness in television medical dramas, and the pharmacist’s role in educating breast-feeding mothers about the use of medications.  She 2011, she has authored the “Pregnancy and Lactation: Therapeutic Considerations” chapter of DiPiro’s Pharmacotherapy: a Pathophysiologic Approach, which is among the most commonly used pharmacotherapy textbooks at colleges of pharmacy in the United States.

Ward KE, Archambault R, Mersfelder TL. Severe adverse skin reactions to NSAIDs and COX-2 inhibitors: a literature review. Am J Health-Syst Pharm 2010;67:2006-13.

Ye Y, Ward KE. The depiction of illness and related matters in two top-ranked primetime network medical dramas in the United States: a content-analysis. J Health Commun 2010;15:555-70.

Bernknopf AC, Karpinski JP, McKeever AL, Peak AS, Smith KM, Smith WD, Timpe EM, Ward KE. Drug Information PRN Opinion Paper: Drug Information: From Education to Practice. Pharmacotherapy 2009;29:331-46.

LaPlante KL, Mersfelder TL, Ward KE, Quilliam BQ. Prevalence of and risk factors for dysglycemia in patients receiving gatifloxacin and levofloxacin in an outpatient setting.
Pharmacotherapy 2008;28:82-9.

Ward KE, Mersfelder TL, LaPlante KL. Oritavancin: Structure, activity, pharmacology and experimental therapeutics. Expert Opin Investig Drugs 2006;15:417-29.

Schucker JJ, Ward KE. A Review of hyperphosphatemia and phosphate-binding medications. Am J Health-Syst Pharm 2005;62:2355-61.

Ward KE, Hume AL. Olmesartan (Benicar) for hypertension. Am Family Phys 2005;72:673-4.

Ward KE, O’Brien B. Pregnancy and lactation: Therapeutic considerations. In: DiPiro JT, Talbert RL, Yee GC, et al, editors. Pharmacotherapy: a Pathophysiologic Approach. 8th ed. New York: McGraw-Hill Medical; 2011. p. 1361-1376.

Ward KE. Drugs and pregnancy. In: Smith KM, Riche DM, Henyan NN, editors. Clinical drug data. 11th ed. New York: McGraw-Hill Medical; 2010. p. 1051-1079.

Hogan TT, Ward KE, McKeever AL, Renfro W, Hastings L. Drug therapy in pregnancy. In: Benrubi GI, editor. Handbook of obstetric and gynecologic emergencies. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2010. p. 224-254.

Dr. Ward serves on the State of Rhode Island Pharmacy and Therapeutics Committee, the Advisory Committee for the Regional Center for Poison Control and Prevention in Boston, Massachusetts, and the University’s Investigational Review Board.  She is a past Chair of the Drug Information Practice and Research Network of the American College of Clinical Pharmacy (ACCP) and was elected to the Phi Lambda Sigma pharmacy leadership society in 2008.